Group 1: Brand Strategy - The brand Winona Baby will continue to focus on pediatric dermatology, specifically addressing infant eczema, and aims to provide comprehensive skincare solutions segmented by season, area, and age [3] - AOXMED will deepen its product matrix in 2025, targeting professional clinics and home care scenarios, with plans to launch new products based on anti-aging concepts [3] - The company has opened 179 new direct-operated stores by the end of last year, focusing on core business districts in first and second-tier cities [3] Group 2: Distribution Channels - As of last year, the OTC distribution channel has covered over 129,000 pharmacies nationwide [3] - The average transaction value on the OMO online sales platform exceeded RMB 1,500, demonstrating strong market penetration [3] Group 3: Technological Innovation - The company collaborates with 63 top-tier hospitals for clinical validation of Winona products, resulting in nearly 500 published academic papers and participation in the formulation of 68 group standards [4] - AI systems are utilized to enhance production speed and blockchain technology is employed to combat counterfeit products, ensuring consumer rights [4] - The company has established research centers in France and Japan and has received international innovation awards for its unique ingredients [4]